(Q34057425)
Statements
Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections (English)
Christopher Lucasti
Ellie Hershberger
Sara Yankelev
Judith Steenbergen